BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)
CUSIP: 09058V103
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 251,185,504
- Total 13F shares
- 176,879,832
- Share change
- -587,846
- Total reported value
- $1,059,530,995
- Put/Call ratio
- 22%
- Price per share
- $5.99
- Number of holders
- 234
- Value change
- -$13,874,803
- Number of buys
- 106
- Number of sells
- 103
Quarterly Holders Quick Answers
What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09058V103:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
6.7%
|
16,774,304
|
$118,762,073 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
15,392,319
|
$108,977,618 | — | 30 Sep 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.1%
|
12,710,818
|
$89,992,591 | — | 30 Sep 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.6%
|
11,550,000
|
$81,774,000 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
10,466,378
|
$74,101,956 | — | 30 Sep 2023 | |
| BRAIDWELL LP |
13F
|
Company |
2.1%
|
5,362,980
|
$37,969,898 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
4,983,207
|
$35,281,106 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.7%
|
4,192,300
|
$29,681,484 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
3,911,077
|
$27,693,915 | — | 30 Sep 2023 | |
| RP Management, LLC |
13F
|
Company |
1.5%
|
3,846,154
|
$27,230,770 | — | 30 Sep 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.3%
|
3,286,000
|
$23,264,880 | — | 30 Sep 2023 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.3%
|
3,185,199
|
$22,551,208 | — | 30 Sep 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.2%
|
3,133,193
|
$22,183,006 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
1.2%
|
2,953,373
|
$20,909,881 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
2,758,813
|
$19,532,396 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1%
|
2,573,340
|
$18,219,248 | — | 30 Sep 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1%
|
2,570,863
|
$18,201,000 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1%
|
2,551,226
|
$18,062,680 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.99%
|
2,479,103
|
$17,552,049 | — | 30 Sep 2023 | |
| Prosight Management, LP |
13F
|
Company |
0.96%
|
2,408,135
|
$17,049,596 | — | 30 Sep 2023 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.95%
|
2,390,948
|
$16,928,000 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.94%
|
2,368,912
|
$16,771,897 | — | 30 Sep 2023 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.91%
|
2,275,638
|
$16,111,517 | — | 30 Sep 2023 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.8%
|
2,017,986
|
$14,287,341 | — | 30 Sep 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
1,970,000
|
$13,947,600 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
1,852,663
|
$13,116,855 | — | 30 Sep 2023 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.73%
|
1,844,019
|
$13,055,655 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.73%
|
1,825,824
|
$12,926,834 | — | 30 Sep 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.72%
|
1,800,000
|
$12,744,000 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.7%
|
1,756,145
|
$12,433,507 | — | 30 Sep 2023 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.67%
|
1,672,313
|
$11,839,976 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.61%
|
1,542,711
|
$10,922,394 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
1,460,807
|
$10,342,514 | — | 30 Sep 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.55%
|
1,380,870
|
$9,776,560 | — | 30 Sep 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.44%
|
1,109,904
|
$7,858,120 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.43%
|
1,091,518
|
$7,727,947 | — | 30 Sep 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.43%
|
1,086,676
|
$7,693,666 | — | 30 Sep 2023 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.39%
|
982,458
|
$6,955,803 | — | 30 Sep 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.37%
|
927,652
|
$6,567,776 | — | 30 Sep 2023 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.35%
|
874,840
|
$6,193,867 | — | 30 Sep 2023 | |
| NORGES BANK |
13F
|
Company |
0.34%
|
846,612
|
$5,994,013 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.32%
|
807,888
|
$5,719,847 | — | 30 Sep 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
791,671
|
$5,605,031 | — | 30 Sep 2023 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.31%
|
775,000
|
$5,487,000 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
767,571
|
$5,434,403 | — | 30 Sep 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.3%
|
750,053
|
$5,310,000 | — | 30 Sep 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.3%
|
746,102
|
$5,282,402 | — | 30 Sep 2023 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
727,480
|
$5,150,558 | — | 30 Sep 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.28%
|
710,651
|
$5,031,409 | — | 30 Sep 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.26%
|
652,000
|
$4,616,160 | — | 30 Sep 2023 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q4 2023
As of 31 Dec 2023,
BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
176,879,832 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, BAKER BROS. ADVISORS LP, BRAIDWELL LP, Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GEODE CAPITAL MANAGEMENT, LLC, and RP Management, LLC.
This page lists
234
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
229
Q4 2023 holders
234
Holder diff
5
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.